Totally-drug-resistant tuberculosis: hype versus hope.
Therapeutic Immunology Division, Department of Laboratory Medicine, Karolinska Institutet, Hälsövägen F79, Huddinge, SE-14186 Stockholm, Sweden; Center for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden. Electronic address: markus.maeurer@ki.se.
Markus
M
Maeurer
Henry M Jackson Foundation-Division of AIDS, Tuberculosis Clinical Research Branch, National Institute of Allergy and infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Marco
M
Schito
Division of Infection and Immunity, University College London, London, UK; Department of Medical Microbiology, University College London Hospitals NHS Trust, London, UK.
Alimuddin
A
Zumla
D054908:Extensively Drug-Resistant Tuberculosis / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D006801:Humans; D009161:Mycobacterium / Q000276:immunology / Q000472:pathogenicity*